chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Dull headache; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 06Mar2021 at 14:00 hours (age at vaccination of 57-years-old) as a single dose for COVID-19 Immunisation. The patients medical history included anxiety. The patient was allergic to PERCOCET. The patient had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 13Feb2021 at 15:30 hours, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The concomitant medications included CLARITIN, vitamin B (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN) and CELEXA within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Mar2021 at 01:00 am (since the second vaccine), the patient experienced dull headache. The patient did not receive any treatment for the event. The clinical outcome of the event dull headache was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vision blurred
Clinical narrative: Blurry vision; Light headedness; Minor headache; This is a spontaneous report received from a contactable consumer, the patient. A 71 -year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207) via an unspecified route of administration on the left arm on 17Mar2021 at 15:00 hours as a single dose for COVID-19 immunisation. Medical history included elevated cholesterol and gout. Patient received other medication (unspecified) within 2 weeks of vaccination (unspecified). Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination the patient has not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021, at 19:00 hours, the patient experienced blurry vision, light headedness and minor headache. No therapeutic measures were taken as a result of the events. The clinical outcome for blurry vision, light headedness and minor headache were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache
Clinical narrative: Severe headache; Tired; Chills; Joint aches; This is a spontaneous report from a contactable consumer, the patient.  A 63-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via unspecified route of administration at left arm on 15Mar2021 at 13:00 as single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to medications, food, or other products. Concomitant medications included fluoxetine, levothyroxine, omeprazole, and vitamin D3; all started on an unknown date for unknown indication and unknown if ongoing. The patient neither underwent test for COVID-19 nor was diagnosed with COVID-19 symptoms prior to vaccination. Since vaccination, the patient was not tested for COVID-19. On 16Mar2021 at 11:00, the patient experienced severe headache, chills, joint aches and was tired. No therapeutic measures were taken for the events. The clinical outcome of the events severe headache, chills, joint aches and tired was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Ear pain, Headache
Clinical narrative: sore throat; cough; body aches; headache; ear aches; chills; loss of appetite; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 17Mar2021 at 13:15 (at the age of 48-years-old), as a single dose for Covid-19 immunisation. Medical history included obesity. Concomitant medications received within two weeks of vaccination was mentioned as yes, however details were not provided. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not tested positive for COVID-19 since having the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 17Mar2021, the patient experienced sore throat, cough, body aches, headache, ear aches, chills, loss of appetite and reported no fever. The patient did not receive treatment for the reported events. The clinical outcome for the events sore throat, cough, body aches, headache, ear aches, chills, loss of appetite was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain
Clinical narrative: sore throat; cough; body aches; headache; ear aches; chills; loss of appetite; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 17Mar2021 at 13:15 (at the age of 48-years-old), as a single dose for Covid-19 immunisation. Medical history included obesity. Concomitant medications received within two weeks of vaccination was mentioned as yes, however details were not provided. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not tested positive for COVID-19 since having the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 17Mar2021, the patient experienced sore throat, cough, body aches, headache, ear aches, chills, loss of appetite and reported no fever. The patient did not receive treatment for the reported events. The clinical outcome for the events sore throat, cough, body aches, headache, ear aches, chills, loss of appetite was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pain
Clinical narrative: Fever; Body ache; Headache; Chills; Muscle ache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199), via an unspecified route of administration in the left arm on 16Mar2021 at 09:15 hours (at the age of 60-years-old), as a single dose for COVID-19 vaccination. The patient took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN5318), via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 hours (at the age of 60-years-old), as a single dose for COVID-19 vaccination. Medical history reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medications included Lipitor (MANUFACTURER UNKNOWN), for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021, around 12 hours post injection, the patient experienced headache which progressed to chills and body ache or muscle ache that lasted all day. On 17Mar2021, the following night, the patient experienced fever up to 104F that lasted for few hours. The patient was treated with Tylenol for fever on an unknown date. The clinical outcome of the events chills, body ache, muscle ache headache and fever was reported as resolving.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Body ache; Headache; Chills; Muscle ache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199), via an unspecified route of administration in the left arm on 16Mar2021 at 09:15 hours (at the age of 60-years-old), as a single dose for COVID-19 vaccination. The patient took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN5318), via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 hours (at the age of 60-years-old), as a single dose for COVID-19 vaccination. Medical history reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medications included Lipitor (MANUFACTURER UNKNOWN), for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021, around 12 hours post injection, the patient experienced headache which progressed to chills and body ache or muscle ache that lasted all day. On 17Mar2021, the following night, the patient experienced fever up to 104F that lasted for few hours. The patient was treated with Tylenol for fever on an unknown date. The clinical outcome of the events chills, body ache, muscle ache headache and fever was reported as resolving.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Euphoric mood, Influenza like illness, Nausea
Clinical narrative: Flu-ish; nauseous; feeling quite wonderful; This is a spontaneous report received from a contactable consumer, the patient . A 60-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 05Mar2021 at 16:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and he was A-1 healthy specimen. Concomitant medications were not reported. The patient received no other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient reported that he was not advised not to drink alcohol, and as this shot happened to be administered on a friday late afternoon, he went home and about an hour later had a glass of Scotch. About an hour after that, he apparently was feeling quite wonderful (loopy)(05Mar2021 at 18:15) but do not remember saying or doing things much at all. The next day the felt nauseous and flu-ish all day long. The patient did not receive any treatment for the event. The clinical outcome of events nauseous ,flu like symptoms and Euphoric mood was recovered with sequelae at the time of the report..  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Cold sweat, Pain
Clinical narrative: Body aches; CLAMMY; Joint aches; Chills; 100 degree Fever; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 17Mar2021 at 10:00 (at the age of 57-year-old), as a single dose for COVID-19 Immunisation. Medical history included high BP (blood pressure) and obese. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 13:00, the patient experienced 100-degree fever, chills, clammy, body and joint aches. No therapeutic measures were taken for the adverse events. The clinical outcome of the events 100-degree fever, chills, clammy, body aches and joint aches was recovering at the time of report.   No further follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; CLAMMY; Joint aches; Chills; 100 degree Fever; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 17Mar2021 at 10:00 (at the age of 57-year-old), as a single dose for COVID-19 Immunisation. Medical history included high BP (blood pressure) and obese. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 13:00, the patient experienced 100-degree fever, chills, clammy, body and joint aches. No therapeutic measures were taken for the adverse events. The clinical outcome of the events 100-degree fever, chills, clammy, body aches and joint aches was recovering at the time of report.   No further follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Chest discomfort, Chest pain, Eustachian tube obstruction, Throat tightness
Clinical narrative: Bronchitis resurfaced; Close up of eustacean tubes, throat, and lungs; Close up of eustacean tubes, throat,and lungs; Close up of eustacean tubes, throat,and lungs; Sharp cutting feeling around the heart and deep pressure/ dull pain in my lungs; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162B2 (Pfizer BioNTech Covid-19 mRNA Vaccine) (Batch No: EN6206) via unspecified route of administration on left arm as a single dose for COVID-19 immunization on 06Mar2021 at 13:15.  The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via unspecified route of administration in the left arm on 05Feb2021 at 10:15 for COVID-19 immunisation. The patients medical history included late onset asthma and bronchitis. Prior to vaccination, the patient was not diagnosed with COVID-19. The patients concomitant medications included prescribed medicines and dietary supplements. The patient was allergic to morphine, omeprazole and oxybutynin. The patient experienced close up of eustachian tubes, throat, and lungs all at once 24 hours after receiving second vaccine  and she had sharp cutting feeling around the heart for one hour and deep pressure/ dull pain in her lungs and severe symptoms lasted for one hour on 07Mar2021. The patient also experienced serious Bronchitis resurfaced within 4 days after vaccination on an unspecified date. The patient received treatment for the adverse events albuterol Sulfate Rescue Inhaler. At the time of the report ,the clinical outcome of the events close up of eustachian tubes, throat, chest pain, sharp cutting feeling around the heart and deep pressure/ dull pain were recovering and bronchitis resurfaced was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: Left armpit felt swollen and painful started 2 days after the shot; Left armpit felt swollen and painful started 2 days after the shot; This is a spontaneous report from a contactable pharmacist. A non pregnant female (adult) patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6203) via an intramuscular route of administration in the left arm on 02Mar2021 at 10:30, as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced left armpit pain and swollen arm (two days after the shot) on 04Mar2021. On 11Mar2021,the patient underwent COVID-19 virus test (nasal swab) and was tested negative. The clinical outcome of the events armpit pain and swollen arm was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Dizziness, Myalgia
Clinical narrative: PAIN IN RIGHT SHOULDER BLADE; Aches and pains in muscles; 99 temp in afternoon; FEELING WOOZY; This is a spontaneous report from a contactable consumer. A 66-years-old elderly non pregnant female patient received second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot no: EN5318), via unspecified route of administration, administered in Arm Right on 02Feb2021 at 16:00 PM for COVID-19 immunisation (age at vaccination was 66-year-old). Medical history included thyroid cancer in 2019 and also patient was allergic to ampicillin, hibiclins. She did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, she was the patient diagnosed with COVID-19 and since the vaccination she has not tested positive for COVID-19. Concomitant medications (within 2 weeks of vaccination) included levothyroxine (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), azelastine (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE), all used for unreported indications. The patient past vaccine history included she took first single dose of BNT162B2 for COVID 19 immunisation on right arm on 12Jan2021 at 14:00 PM, batch number: EL3246). On 03Feb2021 (second day of dose 2), she felt woozy and then was fine until day 6. On 07Feb2021 (late morning at 11:00 AM), she experienced sharp pain in right shoulder blade and on an unknown time on the same date (07Feb2021 in afternoon), her temperature was 99 (unit unknown) and has experienced aches and pains in muscles. Then, she went to bed early and woke up fine next day. No therapeutic measures were taken for the events. On 08Feb2021, the clinical outcome of 99 temperature (body temperature increased), shoulder blade pain and muscle pain were recovered at the time of this report. On an unknown date in Feb2021, the event feeling woozy was recovered. No follow up attempts are possible. Follow up information cannot be expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats
Clinical narrative: Broke out in a profuse sweat while sleeping.; This is spontaneous report from a contactable nurse, the patient. A 64-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL1283), via an unspecified route of administration in the right arm on 24Jan2021 at 10:45, (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included moebius syndrome, obesity and allergic to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications vitamins (unspecified) and reported she did not take any other medications except these after the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EH9899), via an unspecified route of administration in the right arm on 03Jan2021 at 14:30 (at the age of 63-years-old) as a single dose for COVID-19 Immunisation. The patient took past drug MOTRIN 400 mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. On 26Jan2021 at 14:00, the patient broke out in a profuse sweat two nights later while sleeping. The patient did not have any other adverse events. The patient did not receive any treatment for the event. The clinical outcome of the broke out in a profuse sweat two nights while sleeping was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Chills, Fatigue, Headache
Clinical narrative: Fatigue; muscle pain; low grade fever; chills; excessive sweating; headache; back pain; generalized weakness; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route and administrated in the left arm on 16Mar2021 at 16:45 hours (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension which was controlled. Patient was not allergic to medications, food, or other products. Concomitant medication included amlodipine besylate 10mg (MANUFACTURER UNKNOWN) and hydrochlorothiazide 25mg (MANUFACTURER UNKNOWN) for an unknown indication. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 17March2021 at 14:00 hours, patient experienced fatigue, muscle pain, low grade fever, chills, excessive sweating, headache, back pain and generalized weakness. Patient did not receive any treatment for the reported events. On an unknown date in Mar2021, the patient was recovered from the events fatigue, muscle pain, low grade fever, chills, excessive sweating, headache, back pain and generalized weakness.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Fatigue; muscle pain; low grade fever; chills; excessive sweating; headache; back pain; generalized weakness; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route and administrated in the left arm on 16Mar2021 at 16:45 hours (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension which was controlled. Patient was not allergic to medications, food, or other products. Concomitant medication included amlodipine besylate 10mg (MANUFACTURER UNKNOWN) and hydrochlorothiazide 25mg (MANUFACTURER UNKNOWN) for an unknown indication. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 17March2021 at 14:00 hours, patient experienced fatigue, muscle pain, low grade fever, chills, excessive sweating, headache, back pain and generalized weakness. Patient did not receive any treatment for the reported events. On an unknown date in Mar2021, the patient was recovered from the events fatigue, muscle pain, low grade fever, chills, excessive sweating, headache, back pain and generalized weakness.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Arm soreness; Low grade fever; Headache; Body fatigue; Weakness; Dizziness; Chills; This is a spontaneous report from a non-contactable physician, the patient. A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patients medical history was not reported. The patient did not receive any concomitant medications within two weeks prior to the second dose of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Feb2021 at 14:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021 at 05:00, the patient experienced weakness, dizziness, arm soreness, low grade fever, headache, body fatigue and chills. The patient did not receive any treatment for the events. The clinical outcome of the events weakness, dizziness, pain in arm, low grade fever, headache, fatigue and chills were recovering.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm soreness; Low grade fever; Headache; Body fatigue; Weakness; Dizziness; Chills; This is a spontaneous report from a non-contactable physician, the patient. A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patients medical history was not reported. The patient did not receive any concomitant medications within two weeks prior to the second dose of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Feb2021 at 14:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021 at 05:00, the patient experienced weakness, dizziness, arm soreness, low grade fever, headache, body fatigue and chills. The patient did not receive any treatment for the events. The clinical outcome of the events weakness, dizziness, pain in arm, low grade fever, headache, fatigue and chills were recovering.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE, Lot Number: EL3247) via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 Immunisation. Medical history included hypertension. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included BENICAR, SINGULAIR and multivitamins/multiminerals, these medications were used within two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE, batch/lot number: EL3247) via an unspecified route of administration in the left arm on 22Feb2021 at 13:15 as a single dose for COVID-19 Immunisation. The patient experienced sore arm and headache on 17Mar2021 at 18:00. Therapeutic measures were taken as a result of sore arm and headache and included treatment with TYLENOL for headache and used ice on arm. The clinical outcome of the headache and arm in pain was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Pain in extremity
Clinical narrative: Upper back pain; Leg pain, foot pain; Headache; This is a spontaneous report received from a contactable physician. A 53-year-old non pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN5318) intramuscularly on the left arm on 31Jan2021 (at the age of 53-year-old) at 12:00 PM, second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) intramuscularly on the left arm on 28Feb2021 at 12:00 PM (at the age of 53-year-old) as single dose for COVID-19 immunisation. Medical history included systemic lupus, migraine, seasonal allergies and allergy to bactrim. Concomitant medications included zolpidem (MANUFACTURER UNKNOWN), SINGULAIR and UBRELVY. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccine. After the first dose of vaccine, on 01Feb2021, the patient experienced headache, leg pain, foot pain and upper back pain. After the second dose of the vaccine, the events headache, leg pain, foot pain and upper back pain were worsened. The patient received TYLENOL as a therapeutic measure for the events headache, leg pain, foot pain and upper back pain. The clinical outcome of the events headache, leg pain, foot pain, upper back pain was not resolved and the patient was still complaining about her symptoms at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Lip swelling
Clinical narrative: Swollen up lip; Very light chest tightening; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: Unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 14:00, (at age of 41-year-old) as a single dose for COVID-19 immunisation. The patient medical history included high blood pressure and pulmonary hypertension due to left heart disease. The patient was allergic to garlic. Concomitant medication included Atorvastatin (MANUFACTURER UNKNOWN), Lisinopril (MANUFACTURER UNKNOWN), vitamin-D (MANUFACTURER UNKNOWN), Iron (MANUFACTURER UNKNOWN), and Q10 for an unspecified indication from an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 14:00, patient experienced swollen up lip for 10 mins and very light chest tightening. The patient did not receive any treatment for the events. The clinical outcome of the event swollen up lip recovered on 18Mar2021 14:10 and the event very light chest tightening was recovered on an unspecified date in Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Hyperhidrosis, Pyrexia
Clinical narrative: very tired; sweaty; running a 100 degree fever; no appetite; Hurt immediately and could not move left arm; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old male patient received his second dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 28Feb2021 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included generic Lipitor (MANUFACTURER UNKNOWN), FENOFIBRATE within 2 weeks of vaccination.  The patient previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot number: EM9809) via an unspecified route of administration in the left arm on 07Feb2021 at 09:30 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 28Feb2021 at 13:00, the patient was hurt immediately and got worse with time. On 01Mar2021 patient could not move the left arm due to pain and experienced 100degrees fever, no appetite, sweaty and very tired. On 02Mar2021, patient felt much better with the arm and had 40 percentage of mobility and on 03Mar2021 the pain was gone and was even able to work out. No therapeutic measures were taken as a result of the events. Patient recovered from vaccination site pain on 01Mar2021. The clinical outcome of the events fever, no appetite, sweaty and very tired was resolved on an unknown date.   No follow up attempts are needed. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: very tired; sweaty; running a 100 degree fever; no appetite; Hurt immediately and could not move left arm; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old male patient received his second dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 28Feb2021 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included generic Lipitor (MANUFACTURER UNKNOWN), FENOFIBRATE within 2 weeks of vaccination.  The patient previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot number: EM9809) via an unspecified route of administration in the left arm on 07Feb2021 at 09:30 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 28Feb2021 at 13:00, the patient was hurt immediately and got worse with time. On 01Mar2021 patient could not move the left arm due to pain and experienced 100degrees fever, no appetite, sweaty and very tired. On 02Mar2021, patient felt much better with the arm and had 40 percentage of mobility and on 03Mar2021 the pain was gone and was even able to work out. No therapeutic measures were taken as a result of the events. Patient recovered from vaccination site pain on 01Mar2021. The clinical outcome of the events fever, no appetite, sweaty and very tired was resolved on an unknown date.   No follow up attempts are needed. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Low grade fever (99.6 F); Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received unknown dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the left arm on 04Mar2021 at 17:15 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Allergies to medications, food, or other products was reported as none. Concomitant medications included VITAMIN D3 and VITAMIN C, both for unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, the patient experienced low grade fever (99.6 F), body aches and chills. The patient did not receive treatment for the reported events. The clinical outcome of the low grade fever, body aches and chills was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Chills; Fever of 102.2; headache; This is a spontaneous report from a contactable Nurse, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the right arm on 17Mar2021 at 09:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included pacemaker, allergic asthma, history of Hodgkin, hypothyroid and high cholesterol. Allergies to medications, food, or other products was reported to penicillin, codeine, morphine, latex sensitive. Concomitant medications included montelukast (SINGULAIR), rosuvastatin (CRESTOR), levothyroxine (MANUFACTURER UNKNOWN), triamcinolone acetonide (NASACORT) and Vitamin (Unspecified), all for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021 at 10:00, the patient experienced chills, fever of 102.2 and headache. The reported events resulted in Doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the reported events. The clinical outcome of the events chills, fever and headache was recovering.   No follow-up attempts are needed. No further information is expected
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on face; This is a spontaneous report from a contactable consumer, the patient. A 40-years-old male patient received first dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE Lot number: unknown) via unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient was not tested positive for COVID-19 since the vaccination. The patient was allergic to Ibuprofen, Tylenol and Aspirin. The patient was experienced hives on face on 18Mar2021 at 18:30. It was unknown if patient received treatment for the event. The clinical outcome of the event hives was unknown. Information about lot number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Urgent Diarrhea 2 times, 1 hr apart; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6204), via an unspecified route of administration in the right arm on 14Mar2021 at 17:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma, hypertension (HTN), arteriosclerosis and allergy to lisinopril. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included REPATHA, CRESTOR, amlodipine (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN) and probiotic within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 17Mar2021 at 14:00, the patient experienced urgent diarrhoea 2 times, 1 hour apart. The patient did not receive any treatment for the event. Patient recovered from the event diarrhoea on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives; Itching of hands/wrists; This is a spontaneous report received from a contactable consumer, the patient. A 20-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via unspecified route of administration in the left arm on 15Mar2021 at 16:30 (at the age of 20-year-old) for COVID-19 immunisation. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via unspecified route of administration in the left arm on 22Feb2021 at 16:30 for COVID-19 immunisation. The patients concomitant medication included birth control pills. The patient was allergic to peanuts and tree nuts. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. The patient experienced hives and itching of hands/wrists on 16Mar2021 at 23:30 hours. The patient did not receive any treatment for the adverse events. At the time of report, the clinical outcome of the event hives and itching of hands/wrists were not recovered.   No follow-up attempts are needed. No follow-up information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Confusional state, Fatigue, Headache
Clinical narrative: Fever; Chills; Weakness; Tiredness; Nausea; Pain; Extreme headache; Confusion; This is a spontaneous report received from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in her right arm on 23Feb2021 at 09:45 (at the age of 39-years-old), received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in her right arm on 16Mar2021 at 09:45 (at the age of 39-years-old) for COVID-19 immunisation. The patient's medical history included allergic to Penicillin. The patient did not receive any concomitant medications within two weeks prior to the second dose of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 09:45, the patient experienced fever, chills, weakness, tiredness, nausea, pain, extreme headache and confusion. The patient did not receive any treatment for the events. The clinical outcome of the events of fever, chills, weakness, tiredness, nausea, pain, headache and confusion were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Fever; Chills; Weakness; Tiredness; Nausea; Pain; Extreme headache; Confusion; This is a spontaneous report received from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in her right arm on 23Feb2021 at 09:45 (at the age of 39-years-old), received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in her right arm on 16Mar2021 at 09:45 (at the age of 39-years-old) for COVID-19 immunisation. The patient's medical history included allergic to Penicillin. The patient did not receive any concomitant medications within two weeks prior to the second dose of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 09:45, the patient experienced fever, chills, weakness, tiredness, nausea, pain, extreme headache and confusion. The patient did not receive any treatment for the events. The clinical outcome of the events of fever, chills, weakness, tiredness, nausea, pain, headache and confusion were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EP6955), via an unspecified route of administration on the left arm on 15Mar2021 at 14:00 (at the age of 60-year-old) for COVID-19 immunization. Medical history and concomitant medications were not reported. He has no allergies to medications, food or other products. Furthermore, he has not received any other vaccine four weeks prior to COVID-19 vaccine neither was not diagnosed with COVID-19 prior to vaccination. On 15Mar2021 at 18:45, he experienced diarrhea. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken to treat this event. The clinical outcome of the diarrhea was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Alcohol problem, Decreased interest, Fatigue
Clinical narrative: I have always loved beer but since the second COVID shot had zero desire to drink it; I felt drunk after only a few beers; very tired; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old (adult) male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 14Feb2021 at 11:00 hours (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 24Jan2021 at 11:45 hours (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient reported that he always loved beer but since the second COVID shot have had zero desire to drink it on 14Feb2021. On an unspecified date in 2021, in two occasions when he drank, he felt drunk after only a few beers and very tired. The clinical outcome of the events I have always loved beer but since the second COVID shot I had zero desire to drink it, I felt drunk after only a few beers and very tired was unknown at the time of report.   Information about lot number cannot be obtained. No further information is expected.